Deubiquitination and Stabilization of Programmed Cell Death Ligand 1 by Ubiquitin-Specific Peptidase 9, X-Linked in Oral Squamous Cell Carcinoma

Cancer Medicine - United Kingdom
doi 10.1002/cam4.1675
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Expression of Programmed Death Ligand-1 Within Stages of Oral Squamous Cell Carcinoma: Immunohistochemical Analysis

Journal of Advances in Medicine and Medical Research
2020English

Role of Ubiquitin-Specific Peptidase 22 in Carcinogenesis of Human Pharyngeal Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Inflammation Promotes Oral Squamous Carcinoma Immune Evasion via Induced Programmed Death Ligand‑1 Surface Expression

Oncology Letters
Cancer ResearchOncology
2013English

Programmed Death-Ligand 1 Expression Correlates With Diminished CD8+ T Cell Infiltration and Predicts Poor Prognosis in Anal Squamous Cell Carcinoma Patients

Cancer Management and Research
Oncology
2017English

Ubiquitin-Specific Peptidase 9, X-Linked (USP9X) Modulates Activity of Mammalian Target of Rapamycin (mTOR)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy

Cancers
Cancer ResearchOncology
2019English

Programmed Death Ligand 1 in Non-Clear Cell Renal Cell Carcinoma and Correlation With Tumor Microenvironment and Prognostic Factors

Medical Journal of Islamic World Academy of Sciences
2018English

Concordance Among Four Commercially Available, Validated Programmed Cell Death Ligand-1 Assays in Urothelial Carcinoma

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2019English

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

JAMA Dermatology
DermatologyMedicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy